BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8299663)

  • 1. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients.
    Takabatake T; Ohta H; Sasaki T; Satoh S; Ohta K; Ise T; Kobayashi K
    Eur J Clin Pharmacol; 1993; 45(4):321-5. PubMed ID: 8299663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a calcium antagonist on renal hemodynamics in salt-loaded spontaneously hypertensive rats.
    Shimosawa T; Ando K; Fujita T
    Jpn Heart J; 1995 Nov; 36(6):797-805. PubMed ID: 8627985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive rats.
    Tojo A; Kimura K; Matsuoka H; Sugimoto T
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):895-9. PubMed ID: 1282591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
    Ikenaga H; Suzuki H; Saruta T
    Blood Press Suppl; 1992; 3():75-9. PubMed ID: 1343295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of manidipine hydrochloride on renal function in renal parenchymal hypertensive patients].
    Ohashi H; Oda H; Matsuno Y; Watanabe S; Kotoo Y
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):239-45. PubMed ID: 8196220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
    He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
    Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension.
    Kawabata M; Takabatake T; Ohta H; Nakamura S; Hara H; Ohta K; Takakuwa H; Han WH; Kobayashi K
    Blood Press Suppl; 1994; 5():117-21. PubMed ID: 7889193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic characteristics of a new calcium antagonist, manidipine: beneficial effects on renal circulation and vascular changes.
    Nagaoka A
    Am Heart J; 1993 Feb; 125(2 Pt 2):560-5. PubMed ID: 8430600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
    Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of manidipine on renal hemodynamics in essential hypertensive patients: responses to acute stress.
    Maki M; Kawamura H; Hara K; Mitsubayashi H; Suzuki K; Itou S; Usui W; Yasugi T
    Blood Press Suppl; 1992; 3():106-13. PubMed ID: 1343277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
    Hirakata H; Iino K; Ishida I; Kashiwagi M; Yoshinari M; Okuda S; Fujita S; Fujishima M
    Blood Press Suppl; 1992; 3():124-9. PubMed ID: 1343281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.
    Galceran J; Plana J; Felip A; Pou G; Vila J; Sobrino J
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):751-7. PubMed ID: 20528630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and mode of action of manidipine: a new calcium antagonist.
    Iimura O; Shimamoto K
    Am Heart J; 1993 Feb; 125(2 Pt 2):635-41. PubMed ID: 8430610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial.
    Bellinghieri G; Mazzaglia G; Savica V; Santoro D
    Ren Fail; 2003 Sep; 25(5):681-9. PubMed ID: 14575277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M; Ogawa T; Han WH; Takabatake T
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.